Trademark: 97619994
Word
NORMUNITY
Status Date
Monday, March 4, 2024
Filing Date
Wednesday, October 5, 2022
Published for Opposition
Tuesday, July 11, 2023
5 Pharmaceutical preparations for treating human diseases, namely, for treating oncological, autoimmune, and immune-oncological diseases and other related diseases in the fields of oncology, autoimmune, and immune-oncology
42 Medical and scientific research in the field of human diseases; pharmaceutical research and development; pharmaceutical research and development, namely, research and development of pharmaceutical technology in the field of therapeutic antibodies and biopharmaceuticals
The mark consists of "NORMUNITY" in stylized lettering, with a shaded square between the letters "M" and "U".
NORM-UNITY
NORM UNITY
Color is not claimed as a feature of the mark.
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2024
Sou Extension 1 Granted
Mar 4, 2024
Sou Extension 1 Filed
Mar 4, 2024
Sou Teas Extension Received
Sep 5, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 11, 2023
Published For Opposition
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jun 5, 2023
Approved For Pub - Principal Register
Jun 5, 2023
Examiner's Amendment Entered
Jun 5, 2023
Notification Of Examiners Amendment E-Mailed
Jun 5, 2023
Examiners Amendment E-Mailed
Jun 5, 2023
Examiners Amendment -Written
Apr 3, 2023
Notification Of Final Refusal Emailed
Apr 3, 2023
Final Refusal E-Mailed
Apr 3, 2023
Final Refusal Written
Feb 28, 2023
Teas/Email Correspondence Entered
Feb 28, 2023
Correspondence Received In Law Office
Feb 28, 2023
Teas Response To Office Action Received
Dec 8, 2022
Notification Of Priority Action E-Mailed
Dec 8, 2022
Priority Action E-Mailed
Dec 8, 2022
Priority Action Written
Nov 30, 2022
Assigned To Examiner
Oct 22, 2022
Notice Of Design Search Code E-Mailed
Oct 21, 2022
New Application Office Supplied Data Entered
Oct 8, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24